Skip to main content

MECANISMOS MOLECULARES USADOS POR EL RECEPTOR DE QUIMIOQUINAS CCR7 Y LA SINAPSIS INMUNOLOGICA AUTOINMUNE PARA CONTROLAR LAS FUNCIONES DE LAS CELULAS DENDRITICAS

SAF2017-83306-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Editorial: Atypical Functions of Leukocyte Chemoattractant Receptors

  • Rodríguez-Fernández, José Luis
  • Mellado, Mario
  • Thelen, Marcus
  • Murphy, Philip M.
© 2020 Rodríguez-Fernández, Mellado, Thelen and Murphy., Chemoattraction is a process that involves directed cell movement toward extracellular chemical stimuli. It is a fundamental feature of all biological systems that was discovered in the late nineteenth century, when the word “chemotaxis” was coined by the German biologist Wilhelm Pfeffer. Metchnikoff’s 1882 description of macrophages from starfish larvae migrating toward an implanted rose thorn irritant represents a seminal observation of chemoattraction in vivo. Since then immunologists have described many chemoattractants, including nucleotides, adenosine, lipids (e.g., leukotrienes, prostaglandins, and platelet-activating factor), proteolytic fragments of complement proteins (e.g., C3a and C5a), small peptides (e.g., N-formyl peptides), and small proteins (e.g., chemokines, non-chemokine cytokines, and defensins). Chemokines comprise the largest known group of chemoattractants (1, 2)., Work supported by grants SAF2017-83306-R (MICIU) and RIER (RETICS Program/ISCIII) (RD08/0075) (JLR-F); grants SAF2017-82940-R AEI/FEDER, UE and RD12/0012/0006 (RETICS Program/ISCIII) (MM); grants from the SNSF (310030_163336/1 and Sinergia CRSII3_160719) and Helmut Horten Foundation (MT); and supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH (PMM).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The chemokine receptor CCR7 uses distinct signaling modules with biased functionality to regulate dendritic cells

  • Rodríguez-Fernández, José Luis
  • Criado-García, Olga
10 p.-1 fig.-1 tab., Chemotaxis is a molecular mechanism that confers leukocytes the ability to detect gradients of chemoattractants. Chemokine receptors are well-known regulators of chemotaxis in leukocytes; however, they can regulate several other activities in these cells. This information has been often neglected, probably due to the paramount role of chemotaxis in the immune system and in biology. Therefore, the experimental data available on the mechanisms used by chemokine receptors to regulate other functions of leukocytes is sparse. The results obtained in the study of the chemokine receptor CCR7 in dendritic cells (DCs) provide interesting information on this issue. CCR7 guides the DCs from the peripheral tissues to the lymph nodes, where these cells control T cell activation. CCR7 can regulate DC chemotaxis, survival, migratory speed, cytoarchitecture, and endocytosis. Biochemical and functional analyses show: first, that CCR7 uses in DCs the PI3K/Akt pathway to control survival, the MAPK pathway to control chemotaxis, and the RhoA pathways to regulate actin dynamics, which in turn controls migratory speed, cytoarchitecture, and endocytosis; second, that these three signaling pathways behave as modules with a high degree of independence; and third, that although each one of these routes can regulate several functions in different settings, CCR7 promotes in DCs a functional bias in each pathway. The data uncover an interesting mechanism used by CCR7 to regulate the DCs, entailing multifunctional signaling pathways organized in modules with biased functionality. A similar mechanism could be used by other chemoattractant receptors to regulate the functions of leukocytes., This work was supported by grants SAF-2014-53151-R(Ministerio de Economía y Competitividad), SAF2017-83306-R (Ministerio de Ciencia, Innovación y Universidades),and RETICSProgram/InstitutodeSaludCarlosIII(RIER) (RD08/0075)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The actin cytoskeleton at the immunological synapse of dendritic cells

  • Rodríguez-Fernández, José Luis
  • Criado-García, Olga
10 p.-1 fig.-1 tab., Dendritic cells (DCs) are considered the most potent antigen-presenting cells. DCs control the activation of T cells (TCs) in the lymph nodes. This process involves forming a specialized superstructure at the DC-TC contact zone called the immunological synapse (IS). For the sake of clarity, we call IS(DC) and IS(TC) the DC and TC sides of the IS, respectively. The IS(DC) and IS(TC) seem to organize as multicentric signaling hubs consisting of surface proteins, including adhesion and costimulatory molecules, associated with cytoplasmic components, which comprise cytoskeletal proteins and signaling molecules. Most of the studies on the IS have focused on the IS(TC), and the information on the IS(DC) is still sparse. However, the data available suggest that both IS sides are involved in the control of TC activation. The IS(DC) may govern activities of DCs that confer them the ability to activate the TCs. One key component of the IS(DC) is the actin cytoskeleton. Herein, we discuss experimental data that support the concept that actin polarized at the IS(DC) is essential to maintaining IS stability necessary to induce TC activation., JR-F was supported by grants awarded by Ministerio de Economía y Competitividad (SAF2014-53151-R, SAF2017-83306-R, and 2020AEP158 Ayuda Extra.2020 TEC2017-85059-C3-3-R), RIER (RETICS Program/Instituto de Salud Carlos III) (RD08/0075), and Consejería de Educación y Empleo from Comunidad de Madrid (Raphyme, S2010/BMD-2350)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A meta-analysis indicates that the regulation of cell motility is a non-intrinsic function of chemoattractant receptors that is governed independently of directional sensing

  • Rodríguez-Fernández, José Luis
  • Criado-García, Olga
28 p.-4 fig.-4 tab., Chemoattraction, defined as the migration of a cell toward a source of a chemical gradient, is controlled by chemoattractant receptors. Chemoattraction involves two basic activities, namely, directional sensing, a molecular mechanism that detects the direction of a source of chemoattractant, and actin-based motility, which allows the migration of a cell towards it. Current models assume first, that chemoattractant receptors govern both directional sensing and motility (most commonly inducing an increase in the migratory speed of the cells, i.e. chemokinesis), and, second, that the signaling pathways controlling both activities are intertwined. We performed a meta-analysis to reassess these two points. From this study emerge two main findings. First, although many chemoattractant receptors govern directional sensing, there are also receptors that do not regulate cell motility, suggesting that is the ability to control directional sensing, not motility, that best defines a chemoattractant receptor. Second, multiple experimental data suggest that receptor-controlled directional sensing and motility can be controlled independently. We hypothesize that this independence may be based on the existence of separated signalling modules that selectively govern directional sensing and motility in chemotactic cells. Together, the information gathered can be useful to update current models representing the signalling from chemoattractant receptors. The new models may facilitate the development of strategies for a more effective pharmacological modulation of chemoattractant receptor-controlled chemoattraction in health and disease. “We shall not cease from exploration And the end of all our exploring Will be to arrive where we started And know the place for the first time” from “Little Gidding” by T.S. Elliot, This work was supported by grants SAF-2014-53151-R (Ministerio de Economía y Competitividad), SAF2017-83306-R (Ministerio de Ciencia, Innovación y Universidades), RIER (RETICS Program/Instituto de Salud Carlos III) (RD08/0075, RD16/0012/0007) and PID2020-114147RB-100 (Ministerio de Ciencia e Innovación)., Peer reviewed